Skip to main content
SpringerLink
Log in

Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance

  • REVIEW
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

An Erratum to this article was published on 29 April 2010

Abstract

Atrial fibrillation (AF) is an increasingly common arrhythmia that now stands at epidemic proportion, with more than 2.3 million people affected in the USA and over 4.5 million people affected in Western Europe. AF is an expression of underlying heart disease and is increasingly associated with hypertension, congestive heart failure, and ischemic heart disease. It is also a progressive disease secondary to continuous structural remodeling of the atria, which relates to AF itself, to changes associated with aging and to progression of the underlying heart disease. Traditionally, AF has been addressed only after it has already presented with pharmacological and nonpharmacological therapies designed for rhythm or rate control (secondary prevention). Although secondary prevention is the most feasible approach at present, the concept of primary prevention of AF with therapies aimed at preventing the development of substrate and correcting the risk factors for AF has emerged as a strategy, which is likely to produce a larger effect in the general population. Recent experiments provided new insights into AF pathophysiology, which generated background for new mechanism-based therapies. Agents targeting inflammation, oxidative injury, atrial myocyte metabolism, extracellular matrix remodeling, and fibrosis have theoretical advantages as novel therapeutic strategies. In this respect, drugs that are not traditionally antiarrhythmic such as angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, aldosterone antagonists, statins, and omega-3 polyunsaturated fatty acids have shown an antiarrhythmic potential in addition to any treatment effect on the underlying disease. These agents are thought to have an advantage of targeting both the occurrence and progression of the substrate for AF, thus, providing primary and secondary prevention of the arrhythmia. Although first experimental and hypothesis-generating small clinical studies or retrospective analyses have been encouraging, several larger, properly designed, prospective trials have not confirmed earlier observations. This review provides a contemporary evidence-based insight into the possible preventative and reverse remodeling role of statins and polyunsaturated fatty acids in AF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Adam O, Neuberger HR, Böhm M, Laufs U (2008) Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Circulation 118:1285–1283

    Article  PubMed  Google Scholar 

  • Aizer A, Gaziano JM, Manson JE, Buring JE, Albert CM (2006) Relationship between fish consumption and the development of atrial fibrillation in men. Heart Rhythm 3(Suppl):S5 (Abstract)

    Article  Google Scholar 

  • Al Chekakie MO, Akar JG, Wang F, Al Muradi H, Wu J, Santucci P, Varma N, Wilber DJ (2007) The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J Cardiovasc Electrophysiol 18:942–946

    Article  PubMed  Google Scholar 

  • Almroth H, Höglund N, Boman K, Englund A, Jensen S, Kjellman B, Tornvall P, Rosenqvist M (2009) Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study. Eur Heart J 30:827–833

    Article  CAS  PubMed  Google Scholar 

  • Anné W, Willems R, Roskams T, Sergeant P, Herijgers P, Holemans P, Ector H, Heidbüchel H (2005) Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res 67:655–666

    Article  PubMed  Google Scholar 

  • Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK (2003) Inflammation as a risk factor for atrial fibrillation. Circulation 108:3006–3010

    Article  PubMed  Google Scholar 

  • Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG (2008) Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. Circulation 119:606–618

    Article  Google Scholar 

  • Berry J, Passman R, Prineas RJ, van Horn L, Tinker L, Wu LL, Snetselaar L, Goldberger J, Liu K, Lloyd-Jones DM (2008) Fish and omega-3 fatty acid intake and incident atrial fibrillation: the Women’s Health Initiative. Heart Rhythm 5(Suppl):S22 (Abstract)

    Google Scholar 

  • Boland LM, Drzewiecki MM (2008) Polyunsaturated fatty acid modulation of voltage-gated ion channels. Cell Biochem Biophys 52:59–84

    Article  CAS  PubMed  Google Scholar 

  • Brouwer IA, Heeringa J, Geleijnse JM, Zock PL, Witteman JC (2006) Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam study. Am Heart J 151:857–862

    Article  CAS  PubMed  Google Scholar 

  • Calder PC (2006) n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83:1505S–1519S

    CAS  PubMed  Google Scholar 

  • Calo L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, Meo A, Pandozi C, Staibano M, Santini M (2005) n-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 45:1723–1728

    Article  CAS  PubMed  Google Scholar 

  • Camm AJ (2005) Atrial fibrillation—an end to the epidemic? Circulation 112:iii

    PubMed  Google Scholar 

  • Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S (2002) Interventions on prevention of post-operative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 106:75–80

    Article  PubMed  Google Scholar 

  • Da Cunha DN, Hamlin RL, Billman GE, Carnes CA (2007) n-3 (Omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling. Br J Pharmacol 150:281–285

    Article  PubMed  Google Scholar 

  • Dernellis J, Panaretou M (2004) Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25:1100–1117

    Article  CAS  PubMed  Google Scholar 

  • Dernellis J, Panaretou M (2005) Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. Am Heart J 150:1064

    Article  PubMed  Google Scholar 

  • Dickinson MG, Hellkamp AS, Ip JH, Anderson J, Johnson GW, Singh SN, Poole JE, Mark DB, Lee KL, Bardy GH (2006) Statin therapy was associated with reduced atrial fibrillation and flutter in heart failure patients in SCD-HeFT. Heart Rhythm 3(Suppl):S49 (Abstract)

    Article  Google Scholar 

  • Erdogan A, Bayer M, Kollath D, Greiss H, Voss R, Neumann T, Franzen W, Most A, Mayer K, Tillmanns H (2007) Omega AF study: polyunsaturated fatty acids (PUFA) for prevention of atrial fibrillation relapse after successful external cardioversion. Heart Rhythm 4(Suppl):S185–S186 (Abstract)

    Google Scholar 

  • Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D (2008) Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol 51:828–835

    Article  CAS  PubMed  Google Scholar 

  • Fogari R, Derosa G, Zoppi A, Mugellini A, Lazzri P, Preti P, Corradi L (2008) Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension. Circulation 118(Suppl):II–828 (Abstract)

    Google Scholar 

  • Frost L (2005) Vestergaard P n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish diet, cancer, and health study. Am J Clin Nutr 81:50–54

    CAS  PubMed  Google Scholar 

  • Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96:1180–1184

    CAS  PubMed  Google Scholar 

  • Garcia-Fernandez A, Marín F, Mainar L, Roldán V, Martínez JG (2006) Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 98:1299–1300

    Article  PubMed  Google Scholar 

  • Gillis AM, Morck M, Exner DV, Soo A, Rose MS, Sheldon RS, Duff HJ, Kavanagh KM, Mitchell LB, Wyse DG (2008) Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation. Eur Heart J 29:1873–1880

    Article  CAS  PubMed  Google Scholar 

  • Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375

    Article  CAS  PubMed  Google Scholar 

  • Goette A, Lendeckel U, Klein HU (2002) Signal transduction systems and atrial fibrillation. Cardiovasc Res 54:247–258

    Article  CAS  PubMed  Google Scholar 

  • He K (2009) Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease—eat fish or take fish oil supplement? Prog Cardiovasc Dis 52:95–114

    Article  CAS  PubMed  Google Scholar 

  • Hanna IR, Heeke B, Bush H, Brosius L, King-Hageman D, Dudley SC Jr (2006) Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm 3:881–886

    Article  PubMed  Google Scholar 

  • Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27:949–953

    Article  PubMed  Google Scholar 

  • Heidt MC, Vician M, Stracke SK, Stadlbauer T, Grebe MT, Boening A, Vogt PR, Erdogan A (2009) Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thorac Cardiovasc Surg 57:276–280

    Article  CAS  PubMed  Google Scholar 

  • Humphries KH, Lee M, Sheldon R, Ramanathan K, Dorian P, Green M, Kerr CR (2007) Statin use and recurrence of atrial fibrillation after successful cardioversion. Am Heart J 154:908–913

    Article  CAS  PubMed  Google Scholar 

  • Ishii Y, Schuessler RB, Gaynor SL, Yamada K, Fu AS, Boineau JP, Damiano RJ Jr (2005) Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 111:2881–2888

    Article  CAS  PubMed  Google Scholar 

  • Izzo R, de Simone G, Trimarco V, Chinali M, Giudice R, Vasta A, Cimmino CS, De Luca N, Trimarco B (2008) Statins therapy and atrial fibrillation in hypertensive patients. Circulation 118(Suppl):II–802 (Abstract)

    Google Scholar 

  • Jahangiri A, Leifert WR, Patten GS, McMurchie EJ (2000) Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Mol Cell Biochem 206:33–41

    Article  CAS  PubMed  Google Scholar 

  • Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G (2009) Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled ’research perspectives in atrial fibrillation. Europace 11:860–885

    Article  PubMed  Google Scholar 

  • Kotlewski A, Liu ILA, Khan SS, Shen AY, Brar SS (2006) Prevalence of atrial fibrillation and flutter by different HMG-CoA reductase inhibitors and doses in heart failure. J Am Coll Cardiol 47(Suppl):61A (Abstract)

    Google Scholar 

  • Kourliouros A, De Souza A, Roberts N, Marciniak A, Tsiouris A, Valencia O, Camm J, Jahangiri M (2008) Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg 85:1515–1520

    Article  PubMed  Google Scholar 

  • Kourliouros A, Savelieva I, Kiotsekoglou A, Jahangiri M, Camm J (2009) Current concepts in the pathogenesis of atrial fibrillation. Am Heart J 157:243–252

    Article  PubMed  Google Scholar 

  • Kumagai K, Nakashima H, Saku K (2004) The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 62:105–111

    Article  CAS  PubMed  Google Scholar 

  • LaRosa JC, He J, Vupputuri S (1999) Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 282:2340–2346

    Article  CAS  PubMed  Google Scholar 

  • Laurent G, Moe G, Hu X, Holub B, Leong-Poi H, Trogadis J, Connelly K, Courtman D, Strauss BH, Dorian P (2008) Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovasc Res 77:89–97

    Article  CAS  PubMed  Google Scholar 

  • Leaf A, Kang JX, Xiao YF, Billman GE (2003) Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107:2646–2652

    Article  PubMed  Google Scholar 

  • Li GR, Sun HY, Zhang XH, Cheng LC, Chiu SW, Tse HF, Lau CP (2009) Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K + currents and Na + current in human atrial myocytes. Cardiovasc Res 81:286–293

    Article  CAS  PubMed  Google Scholar 

  • Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dörge H, Stamm C, Wassmer G, Wahlers T (2008) Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J 29:1548–1559

    Article  PubMed  Google Scholar 

  • Liakopoulos OJ, Choi YH, Kuhn EW, Wittwer T, Borys M, Madershahian N, Wassmer G, Wahlers T (2009) Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review. J Thorac Cardiovasc Surg 138:678–686

    Article  PubMed  Google Scholar 

  • Liu T, Li L, Korantzopoulos P, Goudevenos JA, Li G (2007) Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 49:1642–1648

    Article  CAS  PubMed  Google Scholar 

  • Liu T, Li G, Korantzopoulos P, Goudevenos JA (2008) Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol 126:160–170

    Article  PubMed  Google Scholar 

  • Lloyd-Jones DM Wang, TJ LEP, Larson MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart study. Circulation 110:1042–1046

    Article  PubMed  Google Scholar 

  • Macchia A, Monte S, Pellegrini F, Romero M, Ferrante D, Doval H, D’Ettorre A, Maggioni AP, Tognoni G (2008) Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction. Eur J Clin Pharmacol 64:627–634

    Article  CAS  PubMed  Google Scholar 

  • Maggioni AP, Fabbri G, Lucci D, Marchioli R, Franzosi MG, Latini R, Nicolosi GL, Porcu M, Cosmi F, Stefanelli S, Tognoni G, Tavazzi L (2009) Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial. Eur Heart J 19:2327–2336

    Article  Google Scholar 

  • Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE (2008) Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul study. Am Heart J 155:303–309

    Article  CAS  PubMed  Google Scholar 

  • Marik PE, Fromm R (2009) The efficacy and dosage effect of corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a systematic review. J Crit Care 24:458–463

    Article  CAS  PubMed  Google Scholar 

  • Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT (2004) Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291:1720–1729

    Article  CAS  PubMed  Google Scholar 

  • McLean DS, Ravid S, Blazing M, Gersh B, Shui A, Cannon CP (2008) Effect of statin dose on incidence of atrial fibrillation: data from the PRavastatin or atOrVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials. Am Heart J 155:298–302

    Article  CAS  PubMed  Google Scholar 

  • Miceli A, Fino C, Fiorani B, Yeatman M, Narayan P, Angelini GD, Caputo M (2009) Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 87:1853–1858

    Article  PubMed  Google Scholar 

  • Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA (2001) Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104:174–180

    CAS  PubMed  Google Scholar 

  • Mithani S, Akbar MS, Johnson DJ, Apple KK, Kuskowski M, Bonawitz-Conlin J, Ward HB, Kelly RF, Mcfalls EO, Bloomfield HE, Ii JM, Adabag S (2009) Statins do not reduce the incidence of postoperative atrial fibrillation after heart surgery in patients treated with postoperative beta-blocker. Heart Rhythm 6(Suppl):S283 (Abstract)

    Google Scholar 

  • Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114:119–125

    Article  PubMed  Google Scholar 

  • Mozaffarian D, Psaty BM, Rimm EB, Lemaitre RN, Burke GL, Lyles MF, Lefkowitz D, Siscovick DS (2004) Fish intake and risk of incident atrial fibrillation. Circulation 110:368–373

    Article  PubMed  Google Scholar 

  • Naji F, Suran D, Kanic V, Vokac D, Sabovic M (2009) Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion. Int Heart J 50:153–160

    Article  CAS  PubMed  Google Scholar 

  • Ninio DM, Murphy KJ, Howe PR, Saint DA (2005) Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model. J Cardiovasc Electrophysiol 16:1189–1194

    Article  PubMed  Google Scholar 

  • Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, Di Sciascio G (2006) Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 114:1455–1461

    Article  CAS  PubMed  Google Scholar 

  • Pellegrini CN, Vittinghoff E, Lin F, Hulley SB, Marcus GM (2009) Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial. Heart 95:704–708

    Article  CAS  PubMed  Google Scholar 

  • Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT (2005) Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 95:764–767

    Article  CAS  PubMed  Google Scholar 

  • Rahimi K, Emberson J, Mcgale P, Majoni W, Merhi A, Asselberg F, Macfarlane PW, Wanner C, Armitage J, Baigent C (2009) Effect of statins on atrial fibrillation: a collaborative meta-analysis of randomised controlled trials. Eur Heart J 30(Suppl):450

    Google Scholar 

  • Richter B, Derntl M, Marx M, Lercher P, Gössinger HD (2007) Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation. Am Heart J 153:113–119

    Article  CAS  PubMed  Google Scholar 

  • Ryu K, Li L, Khrestian CM, Matsumoto N, Sahadevan J, Ruehr ML, Van Wagoner DR, Efimov IR, Waldo AL (2007) Effects of sterile pericarditis on connexins 40 and 43 in the atria—correlation with abnormal conduction and atrial arrhythmias. Am J Physiol Heart Circ Physiol 293:H1231–1241

    Article  CAS  PubMed  Google Scholar 

  • Sakabe M, Shiroshita-Takeshita A, Maguy A, Dumesnil C, Nigam A, Leung TK, Nattel S (2007) Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Circulation 116:2101–2109

    Article  CAS  PubMed  Google Scholar 

  • Saravanan P, O’Neill SC, Bridgewater B, Davidson NC (2009) Fish oils supplementation does not reduce risk of atrial fibrillation following coronary artery bypass surgery. Heart Rhythm 6(Suppl): S283

    Google Scholar 

  • Sarrazin JF, Comeau G, Daleau P, Kingma J, Plante I, Fournier D, Molin F (2007) Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol 50:1505–1512

    Article  CAS  PubMed  Google Scholar 

  • Savelieva I, Camm AJ (2000) Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol 4:369–382

    Article  CAS  PubMed  Google Scholar 

  • Savelieva I, Camm J (2007) Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation? Am Heart J 154:403–406

    Article  CAS  PubMed  Google Scholar 

  • Savelieva I, Camm J (2008) Statins and polyunsaturated fatty acids for treatment of atrial fibrillation. Nat Clin Pract Cardiovasc Med 5:30–41

    Article  CAS  PubMed  Google Scholar 

  • Schwartz GG, Olsson AG, Chaitman B, Goldberg J, Szarek M, Sasiela WJ (2004) Effect of intensive statin treatment on the occurrence of atrial fibrillation after acute coronary syndrome: an analysis of the MIRACL trial. Circulation 110(Suppl):III–740 (Abstract)

    Google Scholar 

  • Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S (2004) The effect of simvastatin and antioxidant vitamins on atrial fibrillation - promotion by atrial tachycardia remodeling in dogs. Circulation 110:2313–2319

    Article  CAS  PubMed  Google Scholar 

  • Shiroshita-Takeshita A, Brundel BJ, Lavoie J, Nattel S (2006) Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs. Cardiovasc Res 69:865–875

    Article  CAS  PubMed  Google Scholar 

  • Shiroshita-Takeshita A, Brundel BJ, Burstein B, Leung TK, Mitamura H, Ogawa S, Nattel S (2007) Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res 74:75–84

    Article  CAS  PubMed  Google Scholar 

  • Skalidis EI, Zacharis EA, Tsetis DK, Pagonidis K, Chlouverakis G, Yarmenitis S, Hamilos M, Manios EG, Vardas PE (2007) Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. Am J Cardiol 99:1258–1262

    Article  CAS  PubMed  Google Scholar 

  • Subramaniam K, Koch CG, Bashour A, O’Connor M, Xu M, Gillinov AM, Starr NJ (2008) Preoperative statin intake and morbid events after isolated coronary artery bypass grafting. J Clin Anesth 20:4–11

    Article  CAS  PubMed  Google Scholar 

  • Tsai CT, Lai LP, Hwang JJ, Wang YC, Chiang FT, Lin JL (2008) Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial. Am Heart J156:65–70

    Article  Google Scholar 

  • Tselentakis EV, Woodford E, Chandy J, Gaudette GR, Saltman AE (2006) Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res 135:68–75

    Article  CAS  PubMed  Google Scholar 

  • Tveit A, Grundtvig M, Gundersen T, Vanberg P, Semb AG, Holt E, Gullestad L (2004) Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 93:780–782

    Article  CAS  PubMed  Google Scholar 

  • Virani SS, Nambi V, Razavi M, Lee VV, Elayda M, Wilson JM, Ballantyne CM (2008) Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J 155:541–546

    Article  CAS  PubMed  Google Scholar 

  • Wazni O, Martin DO, Marrouche NF, Shaaraoui M, Chung MK, Almahameed S, Schweikert RA, Saliba WI, Natale A (2005) C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart 91:1303–1305

    Article  CAS  PubMed  Google Scholar 

  • Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954–1956

    CAS  PubMed  Google Scholar 

  • Xiao YF, Ke Q, Chen Y, Morgan JP, Leaf A (2004) Inhibitory effect of n-3 fish oil fatty acids on cardiac Na+/Ca2+ exchange currents in HEK293t cells. Biochem Biophys Res Commun 321:116–123

    Article  CAS  PubMed  Google Scholar 

  • Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, Ardehali A, Odim J, Laks H, Sen L (2004) Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 109:363–368

    Article  CAS  PubMed  Google Scholar 

  • Young-Xu Y, Jabbour S, Goldberg R, Blatt CM, Graboys T, Bilchik B, Ravid S (2003) Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 92:1379–1383

    Article  CAS  PubMed  Google Scholar 

  • Zacks ES, Okin PM, Min J, Roman MJ, Lee ET, Howard BV, Best LG, Galloway JM, Devereux RB (2006) Association of markers of inflammation with new onset atrial fibrillation in a population-based sample: the Strong Heart Study. Circulation 114(Suppl):11–678 (Abstract)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiac and Vascular Sciences, St. George’s University of London, Cranmer Terrace, London, SW17 0RE, UK

    Irene Savelieva, Antonios Kourliouros & John Camm

Authors
  1. Irene Savelieva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonios Kourliouros
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Camm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irene Savelieva.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s00210-010-0516-7

Rights and permissions

Reprints and permissions

About this article

Cite this article

Savelieva, I., Kourliouros, A. & Camm, J. Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance. Naunyn-Schmied Arch Pharmacol 381, 207–219 (2010). https://doi.org/10.1007/s00210-009-0468-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-009-0468-y

Keywords

Search

Navigation